» Articles » PMID: 39876060

Extension of T Hyperintense Areas in Patients With a Glioma: A Comparison Between High-Quality 7 T MRI and Clinical Scans

Overview
Journal NMR Biomed
Publisher Wiley
Date 2025 Jan 29
PMID 39876060
Authors
Affiliations
Soon will be listed here.
Abstract

Gliomas are highly heterogeneous and often include a nonenhancing component that is hyperintense on T weighted MRI. This can often not be distinguished from secondary gliosis and surrounding edema. We hypothesized that the extent of these T hyperintense areas can more accurately be determined on high-quality 7 T MRI scans. We investigated the extension, volume, and complexity (shape) of T hyperintense areas in patients with glioma on high-quality 7 T MRI scans compared to clinical MRI scans. T hyperintense areas of 28 patients were visually compared and manually segmented on 7 T MRI and corresponding clinical (1.5 T/3 T) MRI scans, and the volume and shape markers were calculated and subsequently compared between scans. We showed extension of the T hyperintense areas via the corpus callosum to the opposite hemisphere in four patients on the 7 T scans that was not visible on the clinical scan. Furthermore, we found a significantly larger volume of the T hyperintense areas on the 7 T scans compared with the clinical scans (7 T scans: 28 mL [12.5-59.1]; clinical scans: 11.9 mL [11.8-56.6]; p = 0.01). We also found a higher complexity of the T hyperintense areas on the 7 T scans compared with the clinical scans (convexity, solidity, concavity index and fractal dimension [p < 0.001]). Our study suggests that high-quality 7 T MRI scans may show more detail on the exact extension, size, and complexity of the T hyperintense areas in patients with a glioma. This information could aid in more accurate planning of treatment, such as surgery and radiotherapy.

References
1.
Verma G, Balchandani P . Ultrahigh field MR Neuroimaging. Top Magn Reson Imaging. 2019; 28(3):137-144. PMC: 6784841. DOI: 10.1097/RMR.0000000000000210. View

2.
Ellingson B, Bendszus M, Boxerman J, Barboriak D, Erickson B, Smits M . Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015; 17(9):1188-98. PMC: 4588759. DOI: 10.1093/neuonc/nov095. View

3.
Giese A, Kluwe L, Laube B, Meissner H, Berens M, Westphal M . Migration of human glioma cells on myelin. Neurosurgery. 1996; 38(4):755-64. View

4.
Kant I, Mutsaerts H, van Montfort S, Jaarsma-Coes M, Witkamp T, Winterer G . The association between frailty and MRI features of cerebral small vessel disease. Sci Rep. 2019; 9(1):11343. PMC: 6683288. DOI: 10.1038/s41598-019-47731-2. View

5.
Morrison M, Lupo J . 7-T Magnetic Resonance Imaging in the Management of Brain Tumors. Magn Reson Imaging Clin N Am. 2020; 29(1):83-102. DOI: 10.1016/j.mric.2020.09.007. View